Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder
- PMID: 17340610
- DOI: 10.1002/da.20303
Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder
Abstract
We report the case of adolescent male with obsessive-compulsive disorder (OCD) who had an incomplete response to combined cognitive-behavioral therapy (CBT) and sertraline before successful augmentation of CBT with aripiprazole. Standardized assessments indicated significant reductions in OCD symptomatology associated with both initial treatment and aripiprazole augmentation. This case suggests that aripiprazole may have utility as an augmenting agent of CBT in adolescents with OCD and underscores the need for conducting controlled studies to test this hypothesis.
(c) 2008 Wiley-Liss, Inc.
Similar articles
-
Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.Psychopharmacology (Berl). 2008 May;197(4):687-8. doi: 10.1007/s00213-008-1091-1. Epub 2008 Feb 10. Psychopharmacology (Berl). 2008. PMID: 18264798 No abstract available.
-
Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 10-week open-label study.Adv Ther. 2011 Apr;28(4):341-8. doi: 10.1007/s12325-011-0011-7. Epub 2011 Mar 21. Adv Ther. 2011. PMID: 21437763 Clinical Trial.
-
Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.Int Clin Psychopharmacol. 2009 Sep;24(5):265-9. doi: 10.1097/YIC.0b013e32832e9b91. Int Clin Psychopharmacol. 2009. PMID: 19629012 Clinical Trial.
-
Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.Int J Neuropsychopharmacol. 2013 Apr;16(3):557-74. doi: 10.1017/S1461145712000740. Epub 2012 Aug 29. Int J Neuropsychopharmacol. 2013. PMID: 22932229 Review.
-
Pharmacological treatment of obsessive-compulsive disorder.Curr Top Behav Neurosci. 2010;2:527-43. doi: 10.1007/7854_2009_12. Curr Top Behav Neurosci. 2010. PMID: 21309125 Review.
Cited by
-
Children with obsessive-compulsive disorder: are they just "little adults"?J Clin Invest. 2009 Apr;119(4):737-46. doi: 10.1172/JCI37563. Epub 2009 Apr 1. J Clin Invest. 2009. PMID: 19339765 Free PMC article. Review.
-
Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.J Child Adolesc Psychopharmacol. 2009 Jun;19(3):265-74. doi: 10.1089/cap.2008.093. J Child Adolesc Psychopharmacol. 2009. PMID: 19519261 Free PMC article. Clinical Trial.
-
Obsessive-Compulsive Disorder Presenting with Compulsions to Urinate Frequently.Indian J Psychol Med. 2016 Jul-Aug;38(4):364-5. doi: 10.4103/0253-7176.185953. Indian J Psychol Med. 2016. PMID: 27570353 Free PMC article.
-
Focus on aripiprazole: a review of its use in child and adolescent psychiatry.J Can Acad Child Adolesc Psychiatry. 2009 Aug;18(3):250-60. J Can Acad Child Adolesc Psychiatry. 2009. PMID: 19718428 Free PMC article.
-
Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders.J Cent Nerv Syst Dis. 2011 Jun 1;3:125-42. doi: 10.4137/JCNSD.S6616. Print 2011. J Cent Nerv Syst Dis. 2011. PMID: 23861643 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical